MML Capital has invested in The Luneau Technology Group. Financial terms weren’t announced. Luneau, of France, supplies diagnostic equipment, analysis and testing in ophthalmology, refractive optometry equipment and cutting equipment and mounting opticians. BNP Paribas advised Luneau.
MML Capital Partners has invested into The Luneau Technology Group (“Luneau”). Luneau is a world leader in the supply of diagnostic equipment, analysis and testing in ophthalmology, refractive optometry equipment and cutting equipment and mounting opticians. Luneau operates in 9 countries, and sells into over 100.
The group, advised by BNP Paribas, received investment from MML Capital Partners, as well as continued support from BNP Paribas, Amundi and Credit Agricole. As a transatlantic investor, MML makes the perfect partner for supporting Luneau in the implementation of its’ strategy. The new capital provides for continuing organic growth, creation of new products and the opportunity to bolt on selective acquisitions.
Marc Abitbol, President and founder of Luneau Technology, said: “We thank our partners for supporting us to date, a period during which our size has trebled. Building on this solid foundation, we have confidence in delivering our growth strategy with new international partner MML Capital and banking groups BNP Paribas and Credit Agricole.”
Henry Louis Mérieux, Managing Partner of MML Capital, says “The enthusiasm of MML in Europe and the United States to partner with Luneau Technology was driven by the impressive international management team and the solid structured growth and development of the business to date year on year.”